DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Estrace (Estradiol Vaginal) - Breast Cancer Female - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Breast Cancer Female (16)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Estrace (Estradiol Vaginal) where reactions include breast cancer female. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Estrace side effects in female

Reported by a lawyer from United States on 2012-07-10

Patient: female, weighing 52.0 kg (114.4 pounds)

Reactions: Breast Cancer Female

Drug(s) suspected as cause:
Premarin
    Dosage: 0.625 mg, unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1995-02-01
    End date: 1997-02-01

Prempro
    Dosage: 0.625/2.5mg
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1997-02-01
    End date: 2003-10-01

Medroxyprogesterone Acetate
    Dosage: unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1995-01-01
    End date: 2003-09-01

Cycrin
    Dosage: 2.5 mg, unk
    Indication: Hormone Replacement Therapy
    Start date: 1995-02-01
    End date: 1997-02-01

Provera
    Dosage: 2.5 mg, unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1995-04-01
    End date: 1996-06-01

Activella
    Dosage: 1mg/0.5mg
    Indication: Hormone Replacement Therapy
    Start date: 2003-01-01
    End date: 2003-08-01

Estrace
    Dosage: 0.1mg/gm
    Indication: Hormone Replacement Therapy

Other drugs received by patient: Fosamax



Possible Estrace side effects in female

Reported by a lawyer from United States on 2012-07-05

Patient: female, weighing 52.0 kg (114.4 pounds)

Reactions: Breast Cancer Female

Drug(s) suspected as cause:
Provera
    Dosage: 2.5 mg, unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1995-04-01
    End date: 1996-06-01

Cycrin
    Dosage: 2.5 mg, unk
    Indication: Hormone Replacement Therapy
    Start date: 1995-02-01
    End date: 1997-02-01

Estrace
    Dosage: 0.1mg/gm
    Indication: Hormone Replacement Therapy

Prempro
    Dosage: 0.625/2.5mg
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1997-02-01
    End date: 2003-10-01

Activella
    Dosage: 1mg/0.5mg
    Indication: Hormone Replacement Therapy
    Start date: 2003-01-01
    End date: 2003-08-01

Medroxyprogesterone Acetate
    Dosage: unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1995-01-01
    End date: 2003-09-01

Premarin
    Dosage: 0.625 mg, unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1995-02-01
    End date: 1997-02-01

Other drugs received by patient: Fosamax



Possible Estrace side effects in female

Reported by a lawyer from United States on 2012-04-25

Patient: female, weighing 64.0 kg (140.8 pounds)

Reactions: Breast Cancer Female, Depression

Drug(s) suspected as cause:
Provera
    Dosage: unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1982-01-01
    End date: 1997-01-01

Prempro
    Dosage: unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1997-01-01
    End date: 2003-01-01

Premarin
    Dosage: unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1982-01-01
    End date: 1997-01-01

Medroxyprogesterone Acetate
    Dosage: unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1982-01-01
    End date: 1997-01-01

Estrace
    Dosage: unk
    Indication: Hormone Replacement Therapy
    Start date: 2003-01-01



Possible Estrace side effects in female

Reported by a lawyer from United States on 2012-03-23

Patient: female

Reactions: Breast Cancer Female

Drug(s) suspected as cause:
Estrace
    Dosage: 2 mg, unk
    Indication: Hormone Replacement Therapy
    Start date: 1994-01-01
    End date: 1995-01-01

Provera
    Dosage: unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1994-01-01
    End date: 1995-01-01

Delestrogen
    Dosage: unk
    Indication: Hormone Replacement Therapy
    Start date: 1994-01-01
    End date: 1995-01-01

Prempro
    Dosage: unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1996-01-01
    End date: 1998-03-01



Possible Estrace side effects in female

Reported by a lawyer from United States on 2012-03-16

Patient: female

Reactions: Breast Cancer Female

Drug(s) suspected as cause:
Provera
    Dosage: unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1994-01-01
    End date: 1995-01-01

Estrace
    Dosage: 2 mg, unk
    Indication: Hormone Replacement Therapy
    Start date: 1994-01-01
    End date: 1995-01-01

Delestrogen
    Dosage: unk
    Indication: Hormone Replacement Therapy
    Start date: 1994-01-01
    End date: 1995-01-01

Prempro
    Dosage: unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1996-01-01
    End date: 1998-03-01



Possible Estrace side effects in female

Reported by a lawyer from United States on 2012-02-16

Patient: female, weighing 63.0 kg (138.6 pounds)

Reactions: Breast Cancer Female

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Provera
    Dosage: 10 mg, unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1989-01-01
    End date: 1997-01-01

Medroxyprogesterone Acetate
    Dosage: unk
    Administration route: Oral

Premarin
    Dosage: 1.25 mg, unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1989-01-01
    End date: 1997-01-01

Estrace
    Dosage: 0.5 mg, unk
    Indication: Hormone Replacement Therapy
    Start date: 1999-01-01
    End date: 1999-01-01

Prempro
    Dosage: 0.625 to 2.5
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1997-01-01
    End date: 2000-01-01

Estradiol
    Dosage: unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1999-01-01
    End date: 1999-01-01



Possible Estrace side effects in female

Reported by a lawyer from United States on 2012-01-25

Patient: female, weighing 70.0 kg (154.0 pounds)

Reactions: Breast Cancer Female

Drug(s) suspected as cause:
Medroxyprogesterone Acetate
    Dosage: unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1983-01-01
    End date: 1997-01-01

Premarin
    Dosage: unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1983-01-01
    End date: 1997-01-01

Provera
    Dosage: unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1983-01-01
    End date: 1997-01-01

Estrace
    Dosage: unk
    Indication: Hormone Replacement Therapy
    Start date: 1993-07-01
    End date: 1996-01-01

Prempro
    Dosage: unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1997-01-01
    End date: 2002-01-01

Other drugs received by patient: Lopid; Synthroid



Possible Estrace side effects in female

Reported by a lawyer from United States on 2012-01-24

Patient: female

Reactions: Breast Cancer Female

Drug(s) suspected as cause:
Cycrin
    Dosage: 2.5 mg, unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1993-09-01
    End date: 1999-06-01

Estrace
    Dosage: 1 mg, unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1990-05-01
    End date: 1991-01-01

Provera
    Dosage: 2.5 mg, unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1993-09-01
    End date: 1999-06-01

Premarin
    Dosage: 0.625 mg, unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1993-09-01
    End date: 1999-06-01



Possible Estrace side effects in female

Reported by a lawyer from United States on 2012-01-13

Patient: female

Reactions: Breast Cancer Female

Drug(s) suspected as cause:
Prempro
    Dosage: unknown
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1992-01-01
    End date: 2001-01-01

Prefest
    Dosage: unk

Estrace
    Dosage: unk

Provera
    Dosage: unk
    Indication: Hormone Replacement Therapy



Possible Estrace side effects in female

Reported by a lawyer from United States on 2012-01-11

Patient: female

Reactions: Breast Cancer Female

Drug(s) suspected as cause:
Estrace
    Dosage: unk

Provera
    Dosage: unk
    Indication: Hormone Replacement Therapy

Prefest
    Dosage: unk

Prempro
    Dosage: unknown
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1992-01-01
    End date: 2001-01-01



Possible Estrace side effects in female

Reported by a lawyer from United States on 2012-01-03

Patient: female, weighing 61.0 kg (134.2 pounds)

Reactions: Breast Cancer Female

Drug(s) suspected as cause:
Estrace
    Indication: Menopausal Symptoms

Activella
    Indication: Menopausal Symptoms

Estradiol
    Dosage: 1 mg, unk
    Indication: Hormone Replacement Therapy
    Start date: 1998-01-19
    End date: 1998-10-22

Prempro
    Dosage: 0.625/2.5mg
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1998-10-22
    End date: 2000-02-08

Provera
    Indication: Menopausal Symptoms

Estrace
    Dosage: 1 mg, unk
    Indication: Hormone Replacement Therapy
    Start date: 1992-08-12
    End date: 1998-10-22

Prempro
    Dosage: 0.625/5mg
    Administration route: Oral
    Start date: 2000-03-02
    End date: 2001-03-21

Prefest
    Indication: Menopausal Symptoms

Prefest
    Dosage: 0.625 mg, unk
    Indication: Hormone Replacement Therapy
    Start date: 2000-02-03
    End date: 2000-03-02

Provera
    Dosage: 5 mg, unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1992-08-12
    End date: 1998-10-22

Activella
    Dosage: 1mg/0.5mg
    Indication: Hormone Replacement Therapy
    Start date: 2001-03-21
    End date: 2001-10-04

Estradiol
    Indication: Menopausal Symptoms

Other drugs received by patient: Flonase



Possible Estrace side effects in female

Reported by a lawyer from United States on 2012-01-03

Patient: female, weighing 63.0 kg (138.6 pounds)

Reactions: Osteoporosis, Breast Cancer Female

Drug(s) suspected as cause:
Estradiol
    Dosage: unk
    Start date: 1997-10-01
    End date: 2002-08-01

Provera
    Dosage: unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1991-05-20
    End date: 1997-06-24

Provera
    Dosage: unk
    Start date: 1997-10-01
    End date: 2002-08-01

Cycrin
    Dosage: unk
    Start date: 1997-10-01
    End date: 2002-08-01

Estrace
    Dosage: unk
    Start date: 1991-05-20
    End date: 1997-06-24

Estrace
    Dosage: unk
    Start date: 1997-10-01
    End date: 2002-08-01

Medroxyprogesterone Acetate
    Dosage: unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1990-02-01
    End date: 2003-06-01

Vagifem
    Dosage: unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 2003-05-23

Estrace
    Dosage: unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1990-02-01
    End date: 2003-06-01

Estradiol
    Dosage: unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1990-02-01
    End date: 2003-06-01

Cycrin
    Dosage: unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1990-02-01
    End date: 2003-06-01



Possible Estrace side effects in female

Reported by a lawyer from United States on 2011-11-01

Patient: female

Reactions: Breast Cancer Female

Drug(s) suspected as cause:
Medroxyprogesterone Acetate
    Dosage: unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1988-01-01
    End date: 1997-12-01

Cycrin
    Dosage: unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy

Provera
    Dosage: unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1990-01-01
    End date: 1995-01-01

Depo-Provera
    Dosage: unk
    Indication: Hormone Replacement Therapy

Estrace
    Dosage: unk
    Indication: Hormone Replacement Therapy
    Start date: 1988-08-01
    End date: 1992-01-01

Prempro
    Dosage: 0.625/2.5mg
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1995-01-01
    End date: 2000-08-01

Curretab
    Dosage: unk
    Indication: Hormone Replacement Therapy
    Start date: 1988-08-01
    End date: 1989-01-01

Premarin
    Dosage: unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1992-01-01
    End date: 1995-01-01

Other drugs received by patient: Cardura; Diclofenac Sodium; Effexor XR; Vioxx; Alprazolam; Acetaminophen and Hydrocodone Bitartrate; Prilosec



Possible Estrace side effects in female

Reported by a lawyer from United States on 2011-10-25

Patient: female, weighing 63.0 kg (138.6 pounds)

Reactions: Breast Cancer Female

Drug(s) suspected as cause:
Estraderm
    Dosage: unk
    Indication: Hormone Replacement Therapy
    Start date: 1998-01-01
    End date: 1999-01-01

Provera
    Dosage: unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1998-01-01
    End date: 2002-01-01

Estradiol
    Dosage: unk
    Indication: Hormone Replacement Therapy
    Start date: 1999-01-01
    End date: 2002-01-01

Prempro
    Dosage: unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy

Premarin
    Dosage: unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 2000-01-01
    End date: 2001-01-01

Premphase (Premarin;cycrin 14 / 14)
    Dosage: unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy

Estrace
    Dosage: unk
    Indication: Hormone Replacement Therapy
    Start date: 1999-01-01

Climara
    Dosage: unk
    Indication: Hormone Replacement Therapy
    Start date: 1998-01-01



Possible Estrace side effects in female

Reported by a lawyer from United States on 2011-10-24

Patient: female, weighing 49.0 kg (107.8 pounds)

Reactions: Breast Cancer Female

Drug(s) suspected as cause:
Prempro
    Dosage: unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1996-10-01
    End date: 2000-06-01

Estrace
    Dosage: unk
    Indication: Hormone Replacement Therapy
    Start date: 1996-01-01
    End date: 1996-09-01

Prefest
    Dosage: unk
    Indication: Hormone Replacement Therapy
    Start date: 2000-11-01



Possible Estrace side effects in female

Reported by a lawyer from United States on 2011-10-21

Patient: female, weighing 54.4 kg (119.7 pounds)

Reactions: Breast Cancer Female

Drug(s) suspected as cause:
Provera
    Dosage: unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1995-12-01
    End date: 1998-01-02

Premarin
    Dosage: unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1997-04-08
    End date: 1998-01-02

Prempro
    Dosage: unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy

Premphase (Premarin;cycrin 14 / 14)
    Dosage: unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy

Estrace
    Dosage: unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1995-12-01
    End date: 1997-02-19

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017